EUROFINS SCIENT Shares Outstanding 2018-2024 | ERFSF
EUROFINS SCIENT shares outstanding history from 2018 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- EUROFINS SCIENT shares outstanding for the quarter ending December 31, 2024 were 0M, a 0% increase year-over-year.
- EUROFINS SCIENT 2024 shares outstanding were 0.195B, a 1.72% decline from 2023.
- EUROFINS SCIENT 2023 shares outstanding were 0.198B, a 0.55% decline from 2022.
- EUROFINS SCIENT 2022 shares outstanding were 0.199B, a 0.8% decline from 2021.
| EUROFINS SCIENT Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 195 |
| 2023 | 198 |
| 2022 | 199 |
| 2021 | 201 |
| 2020 | 196 |
| 2019 | 186 |
| 2018 | 183 |
| 2017 | 180 |
| 2016 | 160 |
| 2015 | 0 |
| EUROFINS SCIENT Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.895B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.784B | 27.53 |
| Elevance Health (ELV) | United States | $87.260B | 11.26 |
| CVS Health (CVS) | United States | $83.934B | 10.43 |
| Cencora (COR) | United States | $57.186B | 19.90 |
| Natera (NTRA) | United States | $22.441B | 0.00 |
| DiDi Global (DIDIY) | China | $22.121B | 23.50 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| Solventum (SOLV) | United States | $12.853B | 13.61 |
| ICON (ICLR) | Ireland | $11.879B | 11.04 |
| CochLear (CHEOY) | Australia | $11.671B | 0.00 |
| Revvity (RVTY) | United States | $11.280B | 19.41 |
| Doximity (DOCS) | United States | $10.697B | 49.52 |
| Viatris (VTRS) | United States | $10.669B | 3.67 |
| Avantor (AVTR) | United States | $9.227B | 13.41 |
| HealthEquity (HQY) | United States | $8.993B | 39.39 |
| Medpace Holdings (MEDP) | United States | $8.737B | 23.21 |
| Sonic Healthcare (SKHHY) | Australia | $8.503B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.460B | 14.62 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.400B | 25.92 |
| BrightSpring Health Services (BTSG) | United States | $3.797B | 34.84 |
| Sotera Health (SHC) | United States | $3.335B | 18.95 |
| Alignment Healthcare (ALHC) | United States | $2.983B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.961B | 38.50 |
| Concentras Parent (CON) | United States | $2.793B | 16.14 |
| Organon (OGN) | United States | $2.618B | 2.78 |
| Ardent Health (ARDT) | United States | $1.938B | 8.26 |
| GeneDx Holdings (WGS) | United States | $1.894B | 72.93 |
| Premier (PINC) | United States | $1.855B | 14.08 |
| Progyny (PGNY) | United States | $1.847B | 40.66 |
| PACS (PACS) | United States | $1.614B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.600B | 32.00 |
| Teladoc Health (TDOC) | United States | $1.258B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.224B | 9.31 |
| Establishment Labs Holdings (ESTA) | $1.073B | 0.00 | |
| CareDx (CDNA) | United States | $1.048B | 16.37 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.907B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.828B | 7.75 |
| QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
| Nutex Health (NUTX) | United States | $0.694B | 10.51 |
| Embecta (EMBC) | United States | $0.587B | 3.95 |
| LifeMD (LFMD) | United States | $0.577B | 0.00 |
| Enhabit (EHAB) | United States | $0.505B | 41.54 |
| InnovAge Holding (INNV) | United States | $0.498B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| SBC Medicals (SBC) | United States | $0.464B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.423B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.257B | 0.00 |
| Oncology Institute (TOI) | United States | $0.236B | 0.00 |
| Beauty Health (SKIN) | United States | $0.197B | 0.00 |
| DocGo (DCGO) | United States | $0.154B | 25.17 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.111B | 0.00 |
| KindlyMD (NAKA) | United States | $0.102B | 0.00 |
| So-Young (SY) | China | $0.095B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| OncoCyte (OCX) | United States | $0.077B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.067B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.048B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |